Friday, June 28, 2013

Epigenetics Drugs and Diagnostic Technologies Market is Expected to Reach USD 5.7 Billion Globally in 2018:Transparency Market Research

The global epigenetic drugs and diagnostic technologies market was valued at USD 1.6 billion in 2011 and is estimated to reach a market worth USD 5.7 billion in 2018 at a CAGR of 19.4% from 2012 to 2018.Growth of the epigenetics market is driven by factors such as increase in aging population, as there is a strong correlation between cancer and aging.

No comments:

Post a Comment